Biopharma products demand specialized knowledge and expertise to ensure safe delivery from the production line to the patient. Wanis Kabbaj, director, global strategy, healthcare logistics, UPS, reviews common breaks in the drug product supply chain; how drug owners balance the risks and costs of doing business in new regions, as well as considerations for regulatory requirements and transit options in foreign nations.